Hyperglycemia during the neutropenic period is associated with a poor outcome in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation.

Source:http://linkedlifedata.com/resource/pubmed/id/17984832

Transplantation 2007 Oct 15 84 7 814-20

Download in:

View as

General Info

PMID
17984832